127 related articles for article (PubMed ID: 38389369)
1. MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract][Full Text] [Related]
2. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
3. Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
Maene C; Salihi RR; Van Nieuwenhuysen E; Han SN; Concin N; Vergote I
Int J Gynecol Cancer; 2021 Jun; 31(6):824-828. PubMed ID: 33858952
[TBL] [Abstract][Full Text] [Related]
4. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
[TBL] [Abstract][Full Text] [Related]
8. Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.
Arezzo F; Cormio G; Mongelli M; Cazzato G; Silvestris E; Kardhashi A; Cazzolla A; Lombardi C; Venerito V; Loizzi V
Arch Gynecol Obstet; 2023 Jun; 307(6):1911-1919. PubMed ID: 36370209
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.
Perniola G; Fischetti M; Tomao F; Di Donato V; Palaia I; Santangelo G; Lecce F; Piccioni MG; Muzii L; Benedetti Panici P
Oncology; 2020; 98(9):603-611. PubMed ID: 32492692
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic efficiency of whole-body
Steiner A; Narva S; Rinta-Kiikka I; Hietanen S; Hynninen J; Virtanen J
Cancer Imaging; 2021 Jan; 21(1):16. PubMed ID: 33482909
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
Prueksaritanond N; Chaisarn P; Yanaranop M
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.
Park DC; Kim JH; Lew YO; Kim DH; Namkoong SE
Gynecol Oncol; 2004 Jan; 92(1):59-63. PubMed ID: 14751139
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy analysis of preoperative neoadjuvant chemotherapy with high-dose dense paclitaxel plus cisplatin in Stages IB2, IIA2, IIB cervical cancer in Iran.
Mousavi AS; Hashemi FS; Gilani MM; Akhavan S; Shariat M
Eur J Gynaecol Oncol; 2016; 37(5):703-709. PubMed ID: 29787015
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
18. The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.
Russo L; Gui B; Miccò M; Panico C; De Vincenzo R; Fanfani F; Scambia G; Manfredi R
Radiol Med; 2021 Aug; 126(8):1055-1063. PubMed ID: 34060027
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
He ZY; Li HY; Yan J; Li SJ; Li DC; Liang ZZ
Trials; 2022 Jul; 23(1):556. PubMed ID: 35804452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
